JSB Market Research: Asthma Therapeutics Market to 2019
GBI Research, a leading business intelligence provider, has released its latest research report, "Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth". The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019.
GBI Research, a leading business intelligence provider, has released its latest research report, "Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth". The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
11 Years of Age<br />
Table 3: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Classification of <strong>Asthma</strong> Severity in Youths ≥ 12<br />
Years of Age and Adults<br />
Table 4: Management of Chronic <strong>Asthma</strong><br />
Table 5: Management of Acute <strong>Asthma</strong><br />
Table 6: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Pipeline, Discovery, 2013<br />
Table 7: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Pipeline, Preclinical, 2013<br />
Table 8: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Pipeline, Phase I, 2013<br />
Table 9: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Pipeline, Phase II, 2013<br />
Table 10: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Pipeline, Phase III, 2013<br />
Table 11: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Pipeline, Filed, 2013<br />
Table 12: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Pipeline, Undisclosed, 2013<br />
Table 13: <strong>Asthma</strong>, Global, <strong>Market</strong> Forecast, 2012-<strong>2019</strong><br />
Table 14: <strong>Asthma</strong>, US, <strong>Market</strong> Forecast, 2012-<strong>2019</strong><br />
Table 15: <strong>Asthma</strong>, Canada, <strong>Market</strong> Forecast, 2012-<strong>2019</strong><br />
Table 16: <strong>Asthma</strong>, UK, <strong>Market</strong> Forecast, 2012-<strong>2019</strong><br />
Table 17: <strong>Asthma</strong>, France, <strong>Market</strong> Forecast, 2012-<strong>2019</strong><br />
Table 18: <strong>Asthma</strong>, Germany, <strong>Market</strong> Forecast, 2012-<strong>2019</strong><br />
Table 19: <strong>Asthma</strong>, Italy, <strong>Market</strong> Forecast, 2012-<strong>2019</strong><br />
Table 20: <strong>Asthma</strong>, Spain, <strong>Market</strong> Forecast, 2012-<strong>2019</strong><br />
Table 21: <strong>Asthma</strong>, Japan, <strong>Market</strong> Forecast, 2012-<strong>2019</strong><br />
List of Figures<br />
Figure 1: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Pipeline, 2013<br />
Figure 2: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Pipeline by Mechanism of Action, 2013<br />
Figure 3: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Pipeline by Mechanism of Action, Phase I, 2013<br />
Figure 4: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Pipeline by Mechanism of Action, Phase II, 2013<br />
Figure 5: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Pipeline by Mechanism of Action, Phase III,<br />
2013<br />
Figure 6: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Clinical Trial Failure Rate, 2013<br />
Figure 7: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Clinical Trial Failure Rates by Mechanism of<br />
Action, Phase I, 2013<br />
Figure 8: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Clinical Trial Failure Rates by Mechanism of<br />
Action, Phase II, 2013<br />
Figure 9: <strong>Asthma</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Clinical Trial Failure Rates by Mechanism of<br />
Action, Phase III, 2013<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Change language